Liu L - Search Results

1

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.

Liu C, Zhou X, Zeng H, Wu D, Liu L. Liu C, et al. Among authors: liu l. Front Oncol. 2021 Mar 18;11:597860. doi: 10.3389/fonc.2021.597860. eCollection 2021. Front Oncol. 2021. PMID: 33816230 Free PMC article.

2

A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.

Zhou X, Du J, Liu C, Zeng H, Chen Y, Liu L, Wu D. Zhou X, et al. Among authors: liu l, liu c. Front Immunol. 2021 Jul 9;12:688215. doi: 10.3389/fimmu.2021.688215. eCollection 2021. Front Immunol. 2021. PMID: 34305920 Free PMC article.

3

Down-regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma.

Luo H, Dong Z, Zou J, Zeng Q, Wu D, Liu L. Luo H, et al. Among authors: liu l. J Surg Oncol. 2012 Jun 1;105(7):699-704. doi: 10.1002/jso.23019. Epub 2011 Dec 28. J Surg Oncol. 2012. PMID: 22213123

4

SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.

Zhang T, Cao C, Wu D, Liu L. Zhang T, et al. Among authors: liu l. Tumour Biol. 2016 Feb;37(2):2379-85. doi: 10.1007/s13277-015-4052-4. Epub 2015 Sep 16. Tumour Biol. 2016. PMID: 26373735

5

miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.

Hua S, Liu C, Liu L, Wu D. Hua S, et al. Among authors: liu l, liu c. Biochem Biophys Res Commun. 2018 Feb 12;496(3):947-954. doi: 10.1016/j.bbrc.2018.01.112. Biochem Biophys Res Commun. 2018. PMID: 29360449

6

A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma.

Zeng H, Liu C, Zhou X, Liu L. Zeng H, et al. Among authors: liu l, liu c. Comb Chem High Throughput Screen. 2022;25(5):906-918. doi: 10.2174/1386207324666210302091432. Comb Chem High Throughput Screen. 2022. PMID: 33653241

7

Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.

Zhou X, Liu C, Zeng H, Wu D, Liu L. Zhou X, et al. Among authors: liu l, liu c. Biosci Rep. 2021 Apr 30;41(4):BSR20202870. doi: 10.1042/BSR20202870. Biosci Rep. 2021. PMID: 33835133 Free PMC article.

8

[Dendritic cell-cytokine induced killer cell immunotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: safety and efficacy].

Guo W, Liu L, Wu D. Guo W, et al. Among authors: liu l. Nan Fang Yi Ke Da Xue Xue Bao. 2014 May;34(5):674-8. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24849434 Clinical Trial. Chinese.

9

Up-regulation of LncRNA SNHG20 Predicts Poor Prognosis in Hepatocellular Carcinoma.

Zhang D, Cao C, Liu L, Wu D. Zhang D, et al. Among authors: liu l. J Cancer. 2016 Mar 19;7(5):608-17. doi: 10.7150/jca.13822. eCollection 2016. J Cancer. 2016. PMID: 27053960 Free PMC article.

10

miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.

Hua S, Lei L, Deng L, Weng X, Liu C, Qi X, Wang S, Zhang D, Zou X, Cao C, Liu L, Wu D. Hua S, et al. Among authors: liu l, liu c. Oncogene. 2018 Mar;37(12):1624-1636. doi: 10.1038/s41388-017-0057-3. Epub 2018 Jan 16. Oncogene. 2018. PMID: 29335523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,214 results

Search Page

Filters